Internal Medicine, Endocrinology, Diabetes, & Metabolism · Dearborn, MI
NPI
1639195456
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1637 Monroe St
Dearborn, MI, 48124
Phone (313) 757-0157
Groups this clinician bills Medicare through
Medicare paid, 2024
$214K
3,182 services
Medicare patients, 2024
802
Average age 72
Drug cost, 2024
$5.4M
10,628 prescriptions
Company payments, 2025
$1,955
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mohammad Saleh was code 99232 (hospital e&m - subsequent), 1,088 times for 229 patients. In total Mohammad Saleh billed 3,182 services in 28 codes, and Medicare paid $214K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-04-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,088 | 229 | $62.90 | $68K |
| 99214 Office E&M - Established | Office | 871 | 528 | $95.84 | $83K |
| 82947 Clinical Chemistry | Office | 249 | 175 | $3.71 | $924 |
| 76536 Ultrasound - Nonspecific | Office | 176 | 162 | $82.80 | $15K |
| 99222 Hospital E&M - Initial | Facility | 150 | 134 | $104.76 | $16K |
| 95251 Test - Miscellaneous | Office | 133 | 80 | $26.96 | $3,585 |
| 83036 Blood Count | Office | 113 | 91 | $9.44 | $1,066 |
| 99457 E&M - Miscellaneous | Office | 90 | 20 | $38.07 | $3,426 |
| 99204 Office E&M - New | Office | 59 | 59 | $125.21 | $7,387 |
| 99454 E&M - Miscellaneous | Office | 43 | 15 | $36.45 | $1,567 |
| 99223 Hospital E&M - Initial | Facility | 40 | 40 | $137.99 | $5,520 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 24 | 16 | $36.72 | $881 |
| 10005 Other Organ Systems | Office | 23 | 20 | $102.59 | $2,360 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 22 | 16 | $47.88 | $1,053 |
| 99442 Telephone Services | Office | 20 | 18 | $59.32 | $1,186 |
By year: 2022 $259K for 3,692 services; 2023 $227K for 3,137 services; 2024 $214K for 3,182 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82947 Clinical Chemistry | 249 | 175 | $3.71 | $924 |
| 83036 Blood Count | 113 | 91 | $9.44 | $1,066 |
Medicare prescription drug claims, 2024
In 2024, the drug Mohammad Saleh prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,208 prescriptions and refills. In total Mohammad Saleh wrote 10,628 Medicare prescriptions that cost $5.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,208 | 3,110 | 364 | $15K |
| Ozempic Semaglutide | 744 | 1,428 | 196 | $1.3M |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 632 | 1,488 | 202 | $113K |
| Metformin Hcl Generic | 592 | 1,382 | 183 | $5,357 |
| Jardiance Empagliflozin | 560 | 1,186 | 158 | $661K |
| Mounjaro Tirzepatide | 404 | 571 | 92 | $590K |
| Metformin Hcl Er Metformin Hcl | 398 | 1,029 | 144 | $5,624 |
| Trulicity Dulaglutide | 287 | 472 | 74 | $445K |
| Novolog Flexpen Insulin Aspart | 275 | 563 | 111 | $81K |
| Atorvastatin Calcium Generic | 270 | 624 | 99 | $3,893 |
| Humalog Kwikpen U-100 Insulin Lispro | 263 | 571 | 94 | $84K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 250 | 610 | 118 | $29K |
| Januvia Sitagliptin Phosphate | 250 | 520 | 73 | $268K |
| Tresiba Flextouch U-100 Insulin Degludec | 232 | 507 | 64 | $176K |
| Farxiga Dapagliflozin Propanediol | 181 | 337 | 53 | $183K |
Brand drugs: 5,721 claims; generic drugs: 3,964 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mohammad Saleh $1,955 ($1,955 in general payments such as food, travel and fees) from 28 companies. The largest payer was Amgen Inc. with $387.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.